Contains fulltext : 206059.pdf (publisher's version ) (Open Access
Background: Tumor-infiltrating lymphocytes (TILs) are clinically significant in triple-negative brea...
It is estimated that breast cancer incidences will increase by more than 50% by 2030 from 2011. Mito...
Purpose. Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive disease with poorer ...
Context.-Mitotic count is an important histologic criterion for grading and prognostication in phyll...
Background: Triple negative breast cancer (TNBC) is a heterogenous cancer type which lacks the recep...
The proliferation marker mitotic activity index is the strongest prognostic indicator in lymph node-...
The proliferative activity of breast tumors, which is routinely estimated by counting of mitotic fig...
Contains fulltext : 88107.pdf (publisher's version ) (Closed access)We evaluated w...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Background: Current prognostic gene signatures for breast cancer mainly reflect proliferation status...
The absence of a robust risk stratification tool for triple negative breast cancer (TNBC) underlies ...
AbstractTriple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous...
Triple negative breast cancer (TNBC) accounts for approximately 15% of breast cancer cases. TNBC is ...
PurposeTriple-negative breast cancer (TNBC) is an aggressive disease lacking specific biomarkers to ...
The volume-corrected mitotic index (M/V-Index) was shown to provide prognostic value in invasive bre...
Background: Tumor-infiltrating lymphocytes (TILs) are clinically significant in triple-negative brea...
It is estimated that breast cancer incidences will increase by more than 50% by 2030 from 2011. Mito...
Purpose. Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive disease with poorer ...
Context.-Mitotic count is an important histologic criterion for grading and prognostication in phyll...
Background: Triple negative breast cancer (TNBC) is a heterogenous cancer type which lacks the recep...
The proliferation marker mitotic activity index is the strongest prognostic indicator in lymph node-...
The proliferative activity of breast tumors, which is routinely estimated by counting of mitotic fig...
Contains fulltext : 88107.pdf (publisher's version ) (Closed access)We evaluated w...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Background: Current prognostic gene signatures for breast cancer mainly reflect proliferation status...
The absence of a robust risk stratification tool for triple negative breast cancer (TNBC) underlies ...
AbstractTriple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous...
Triple negative breast cancer (TNBC) accounts for approximately 15% of breast cancer cases. TNBC is ...
PurposeTriple-negative breast cancer (TNBC) is an aggressive disease lacking specific biomarkers to ...
The volume-corrected mitotic index (M/V-Index) was shown to provide prognostic value in invasive bre...
Background: Tumor-infiltrating lymphocytes (TILs) are clinically significant in triple-negative brea...
It is estimated that breast cancer incidences will increase by more than 50% by 2030 from 2011. Mito...
Purpose. Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive disease with poorer ...
DOI
Add to ORKG